Polly Murphy

Polly Murphy

Director/Board Member at ATEA PHARMACEUTICALS, INC.

Net worth: 1 M $ as of 31/07/2026

61 year
Health Technology
Consumer Services

Profile

Dr. Polly A. Murphy is a Chief Business Officer at Avadel Pharmaceuticals Plc, an Independent Director at Celcuity, Inc. and an Independent Director at Atea Pharmaceuticals, Inc. She is on the Board of Directors at Celcuity, Inc. and Atea Pharmaceuticals, Inc. Dr. Murphy was previously employed as a Chief Business Officer by UroGen Pharma Ltd., a Vice President-Commercial Development by Pfizer Inc., and a Senior VP-Business & Scientific Services by The Scripps Research Institute.
She received her MBA from Nova Southeastern University, Inc. and a doctorate degree from Iowa State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/06/2026 121,745 ( 0.15% ) 572 202 $ 31/07/2026
10/06/2026 5,000 ( 0.01% ) 431 900 $ 31/07/2026

Polly Murphy active positions

CompaniesPositionStart
ATEA PHARMACEUTICALS, INC. Director/Board Member 01/08/2020
CELCUITY INC. Director/Board Member 12/09/2022
AVADEL PHARMACEUTICALS PLC Corporate Officer/Principal 01/05/2024

Former positions of Polly Murphy

CompaniesPositionEnd
UROGEN PHARMA LTD. Corporate Officer/Principal 01/05/2024
PFIZER INC. Corporate Officer/Principal 01/08/2020
Corporate Officer/Principal 01/08/2008
See the detail of Polly Murphy's experience

Training of Polly Murphy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

98

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology